Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (11-20 of 373) with videos related to

Pageof 38
Sort By:
BMJ (Clinical Research Ed.)|June 3, 1995
Poor response to erythropoietinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2004
Once-weekly erythropoietic therapy: is there a difference between the available preparations?Iain C Macdougall
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 13, 2002
Hyporesponsiveness to anemia therapy--what are we doing wrong?I C MacDougall
Kidney International. Supplement|May 2, 2002
Darbepoetin alfa: a new therapeutic agent for renal anemiaIain C Macdougall
Current Opinion in Nephrology and Hypertension|November 1, 1994
Monitoring of iron status and iron supplementation in patients treated with erythropoietinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2009
Biosimilar epoetinsIain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2009
Anaemia ERBP Position statementIain C Macdougall
Seminars in Oncology|July 22, 1998
Quality of life and anemia: the nephrology experienceI C Macdougall
American Annals of the Deaf|February 1, 1979
The development of visual processing and short-term memory in deaf and hearing childrenJ C MacDougall
Current Opinion in Nephrology and Hypertension|July 27, 2022
Hypoxia-inducible factor prolyl hydroxylase enzyme inhibitors: ready for primetime?Iain C Macdougall
Pageof 38

Showing results (11-20 of 373) with videos related to

Sort By:
Pageof 38
BMJ (Clinical Research Ed.)|June 3, 1995
Poor response to erythropoietinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2004
Once-weekly erythropoietic therapy: is there a difference between the available preparations?Iain C Macdougall
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 13, 2002
Hyporesponsiveness to anemia therapy--what are we doing wrong?I C MacDougall
Kidney International. Supplement|May 2, 2002
Darbepoetin alfa: a new therapeutic agent for renal anemiaIain C Macdougall
Current Opinion in Nephrology and Hypertension|November 1, 1994
Monitoring of iron status and iron supplementation in patients treated with erythropoietinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2009
Biosimilar epoetinsIain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2009
Anaemia ERBP Position statementIain C Macdougall
Seminars in Oncology|July 22, 1998
Quality of life and anemia: the nephrology experienceI C Macdougall
American Annals of the Deaf|February 1, 1979
The development of visual processing and short-term memory in deaf and hearing childrenJ C MacDougall
Current Opinion in Nephrology and Hypertension|July 27, 2022
Hypoxia-inducible factor prolyl hydroxylase enzyme inhibitors: ready for primetime?Iain C Macdougall
Pageof 38